SCHEMBL14765191

SCHEMBL14765191

Cc1ccc2c(c1)NC(=O)C(C)N2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 2/20 0.61
BRPF1 P55201 1/20 0.61
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CSNK1G1 Q9HCP0 1/20 0.44
GSK3B P49841 1/20 0.44
TSHR P16473 1/20 0.42
BRD4 O60885 2/20 0.41
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
POLB P06746 2/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 3/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP2C9 P11712 1/20 0.39
RAB9A P51151 1/20 0.39
MCL1 Q07820 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908117 0.81 ROS1 (0.54) CREBBPBRPF1MEN1KMT2ACSNK1G1
SCHEMBL2136049 0.80 BRPF1 (0.59) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL16053338 0.80 BRPF1 (0.59) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL14764993 0.77 BRPF1 (0.56) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL12597037 0.77 CREBBP (0.66) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL10327064 0.76 CREBBP (1.00) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL1101924 0.76 CREBBP (1.00) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL7668762 0.76 CREBBP (1.00) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL29893035 0.76 MEN1 (0.64) CREBBPBRPF1MEN1KMT2AGSK3B
SCHEMBL27077382 0.76 MEN1 (0.64) CREBBPBRPF1MEN1KMT2AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed